High-grade transformation of adenoid cystic carcinomas: A study of the expression of GLUT1 glucose transporter and of mitochondrial antigen

Journal of Clinical Pathology

Volumn 63, Issue 7, 2010, Pages 615-619

  Bonfitto, V L ^a   Demasi, A P ^b   Costa, A F ^a   Bonfitto, J F ^a   Araujo, V C ^b   Altemani, A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL ANTIGEN; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; MITOCHONDRION ANTIGEN; PROTEIN P63; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER GROWTH; CANCER MORTALITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AUTOANTIGENS; CARCINOMA, ADENOID CYSTIC; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SALIVARY GLAND NEOPLASMS; YOUNG ADULT;

EID: 77955730756     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.075390     Document Type: Article

References (23)

1. El-Naggar AK, Huvos AG. Adenoid cystic carcinoma. In: Barnes LE, eds. World Health Organization classification of tumour. Head and neck tumours. Pathology and genetics. Albany, US: IARC press, 2005:223-4.
2. Seethala RR, Hunt JL, Baloch ZW, et al. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol 2007;31:1683-94.
3. Cheuk W, Chan JKC, Ngan RKC. Dedifferentiation in adenoid cystic carcinoma of salivary gland. An uncommon complication associated with an accelerated clinical course. Am J Surg Pathol 1999;24:465-72. (Pubitemid 29160008)
4. Moles MA, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:177-80.
5. Chau Y, Hongyo T, Aozasa K, et al. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol 2001;32:1403-7. (Pubitemid 34038678)
6. Ide F, Mishima K, Saito I, et al. Small foci of high-grade carcinoma cells in adenoid cystic carcinoma represent an incipient phase of dedifferentiation. Histopathology 2003;43:604-6. (Pubitemid 38002350)
7. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol 2003;16:1265-72. (Pubitemid 38018609)
8. Sato K, Ueda Y, Sakurai A, et al. Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma. Virchows Arch 2006;448:204-8. (Pubitemid 43237887)
9. Handra-Luca A, Planchard D, Fouret P. Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation. Oral Oncol 2009;45:208-9.
10. Malhotra KP, Agrawal V, Pandey R. High grade transformation in adenoid cystic Carcinoma of the parotid: report of a case with cytologic, histologic and immunohistochemical study. Head Neck Pathol;3:310-14.(E pub 2009 Jun 20).
11. Jones RG, Thompson CB. Tumour suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 2009;23:537-48.
12. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
13. Moreno-Sánchez R, Rodriguez-Enriquez A, Marin-Hernandez A, et al. Energy metabolism in tumour cells. FEBS J 2007;274:1393-418.
14. Younes M, Lechago LV, Somoano JR, et al. Wide expression of the human erythrocyte glucose transporter GLUT1 in human cancers. Cancer Res 1996;56:1164-7.
15. Younes M, Brown RW, Stephenson M, et al. Overexpression of GLUT1 and GLUT3 in stage 1 non-small cell lung carcinoma is associated with poor survival. Cancer 1997;80:1046-51. (Pubitemid 27427603)
16. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998;83:34-40. (Pubitemid 28299626)
17. Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 2001;92:634-41. (Pubitemid 32735200)
18. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn ' t tell us. J Nat Cancer Inst 2002;94:883-93. (Pubitemid 34778087)
19. Wening BM. Neoplasms of salivary glands. 2nd edn. In: Wening BM, Heffess CS, eds. Atlas of head and neck pathology. China: Saunders Elsevier Press, 2008:628-31.
20. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596-604. (Pubitemid 32601241)
21. Amann T, Ulrike M, Hartmann A, et al. GLU1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009;174:1544-52.
22. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 1996;2:1151-4. (Pubitemid 26238445)
23. Erkan M, Reiser-Erkan C, Michalsky CW, et al. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 2009;11:497-508.